CORRIGENDUM: JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias

The authors apologize for the error in the typesetting. Corrections are shown below.

1) Page 1121, Figure 4. ICD indications for coronary artery disease.

Incorrect:

Primary prevention (1) ≥48 days after onset of AMI or ≥90 days after revascularization

Correct:

Primary prevention (1) ≥40 days after onset of AMI or ≥90 days after revascularization

2) Page 1123, Figure 5. ICD indications for non-ischemic cardiomyopathy with left ventricular dysfunction.

Incorrect:

In the box at the bottom-left. “(1) LVEF ≤35%”

Correct:

In the box at the bottom-left. “(1) LVEF ≤35%” has been removed and renumbered the following items in this box.

3) Page 1126, Figure 6. ICD indication for patients with uncertain diagnosis of syncope.

Incorrect:

In the box at the bottom-middle. NYHA class I or IV.

Correct:

In the box at the bottom-middle. NYHA class I–IV.

4) Page 1138, Table 35. Recommendations and Evidence Levels for CRT in Patients With Reduced LV Systolic Function and Indication for Ventricular Pacing, or Who Have a High Percentage of RV Pacing After Implantation of a Pacemaker or an ICD.

Incorrect:

(2) LVEWF <50%

Correct:

(2) LVEWF ≤50%

5) Page 1139, Table 36. Recommendations and Evidence Levels for CRT in Patients With AF.

Incorrect:

(3) LBBB with QRS duration ≥150 ms or non-LBBB with QRS duration ≥150 ms

Correct:

(3) LBBB with QRS duration ≥120 ms or non-LBBB with QRS duration ≥150 ms

6) Page 1141, Table 38. Recommendations and Evidence Levels for Patients With Infection of CIED System. We added the reference number in the footnote.

Correct:

In the JCS guideline on infective endocarditis,⁴¹⁰ part of the recommendation level is inconsistent with that in this guideline, because the recommendations for surgical removal and cardiac vegetation are described in the JCS guideline on infective endocarditis.

7) Page 1153, Table 55. Number of Sessions, Complication Rates, and Acute Success Rates of Ablation.

Incorrect:

Success rate of concealed WPW: 96.6%

Success rate of PAC: 8.5%

Correct:

Success rate of concealed WPW: 96.3%

Success rate of PAC: 88.5%

8) Page 1176, Table 66. Incidence of Atrial Tachycardia (AT) After Various Procedures of AF Catheter Ablation.

Incorrect:

Segmental PVI^870,971

Correct:

Segmental PVI^870,871

9) Page 1177, Table 67. Recommendations and Evidence Levels for Anticoagulation Strategies Before, During, and After AF Ablation.

Incorrect:

systemic anticoagulation with warfarin or a DOAC should be considered for at least 3 months before AF ablation.

Correct:

systemic anticoagulation with warfarin or a DOAC should be considered for at least 3 weeks before AF ablation.

10) Page 1194, Table 77. Recommendations and Evidence Levels for Catheter Ablation of Tachyarrhythmias in Children With Congenital Heart Disease.

Incorrect:

In pediatric patients with CHD, body weight ≥15 kg, and SVT with acute hemodynamic compromise, catheter ablation of SVT may be considered

Correct:

In pediatric patients with CHD, body weight <15 kg, and SVT with acute hemodynamic compromise, catheter ablation of SVT may be considered

11) Page 1202, Table 84. Conditions and Management Categories of Exercise for Patients With Right-to-Left Shunt Heart Disease.

Incorrect:

C-prohibited, D-prohibited in the “Management category” column.

Correct:

C, D in the “Management category” column.

12) We also amended the misspelling in the foot notes of Tables 14, 15, 16, 18, 19, 20, 22, 32, 42, 69, 70, 71, 72, and Figures 6, 7.

Incorrect:

ventriculat

Incorrect:

ventricular